CID 56843377

Gataparsen sodium

Structural Information

Molecular Formula
C204H278N59O111P17S17
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7C(OC(C7OCCOC)N8C=NC9=C8N=C(NC9=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O
InChI
InChI=1S/C204H278N59O111P17S17/c1-85-46-246(194(279)227-157(85)205)124-36-96(358-375(290,392)324-59-109-101(41-129(343-109)251-51-90(6)172(269)240-199(251)284)363-380(295,397)330-65-115-104(44-132(348-115)258-79-223-137-165(258)229-190(210)233-178(137)275)366-383(298,400)328-63-112-102(42-130(346-112)252-52-91(7)173(270)241-200(252)285)364-381(296,398)331-66-116-105(45-133(349-116)259-80-224-138-166(259)230-191(211)234-179(138)276)367-384(299,401)334-69-120-145(153(319-32-24-311-16)186(354-120)260-81-221-135-160(208)215-76-218-163(135)260)372-391(306,408)338-72-121-146(154(320-33-25-312-17)187(355-121)261-82-222-136-161(209)216-77-219-164(136)261)373-389(304,406)336-70-118-143(151(317-30-22-309-14)184(352-118)255-55-94(10)176(273)244-203(255)288)369-386(301,403)333-68-117-141(265)149(315-28-20-307-12)182(351-117)253-53-92(8)174(271)242-201(253)286)107(340-124)58-323-377(292,394)360-98-38-126(248-48-87(3)169(266)237-196(248)281)342-108(98)61-326-378(293,395)361-99-39-127(249-49-88(4)170(267)238-197(249)282)345-111(99)62-327-382(297,399)365-103-43-131(257-78-220-134-159(207)214-75-217-162(134)257)347-114(103)64-329-379(294,396)362-100-40-128(250-50-89(5)171(268)239-198(250)283)344-110(100)60-325-376(291,393)359-97-37-125(247-47-86(2)158(206)228-195(247)280)341-113(97)67-332-385(300,402)371-147-123(357-188(155(147)321-34-26-313-18)262-83-225-139-167(262)231-192(212)235-180(139)277)74-339-388(303,405)370-144-119(353-185(152(144)318-31-23-310-15)256-56-95(11)177(274)245-204(256)289)71-337-390(305,407)374-148-122(356-189(156(148)322-35-27-314-19)263-84-226-140-168(263)232-193(213)236-181(140)278)73-335-387(302,404)368-142-106(57-264)350-183(150(142)316-29-21-308-13)254-54-93(9)175(272)243-202(254)287/h46-56,75-84,96-133,141-156,182-189,264-265H,20-45,57-74H2,1-19H3,(H,290,392)(H,291,393)(H,292,394)(H,293,395)(H,294,396)(H,295,397)(H,296,398)(H,297,399)(H,298,400)(H,299,401)(H,300,402)(H,301,403)(H,302,404)(H,303,405)(H,304,406)(H,305,407)(H,306,408)(H2,205,227,279)(H2,206,228,280)(H2,207,214,217)(H2,208,215,218)(H2,209,216,219)(H,237,266,281)(H,238,267,282)(H,239,268,283)(H,240,269,284)(H,241,270,285)(H,242,271,286)(H,243,272,287)(H,244,273,288)(H,245,274,289)(H3,210,229,233,275)(H3,211,230,234,276)(H3,212,231,235,277)(H3,213,232,236,278)
InChIKey
SEMODNSMTKOTGN-UHFFFAOYSA-N
Compound name
1-[4-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[2-[[[2-[[[2-[[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[hydroxy-[2-(hydroxymethyl)-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

9
References

0
Patents

6399.8716 Da
Monoisotopic Mass

-8.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 6400.8789 311.5
[M+Na]+ 6422.8608 311.5
[M-H]- 6398.8643 311.5
[M+NH4]+ 6417.9054 311.5
[M+K]+ 6438.8348 311.5
[M+H-H2O]+ 6382.8689 311.5
[M+HCOO]- 6444.8698 311.5
[M+CH3COO]- 6458.8855 311.5
[M+Na-2H]- 6420.8463 311.5
[M]+ 6399.8711 311.5
[M]- 6399.8721 311.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.